New Therapeutic Targets in Antineutrophil Cytoplasm Antibody–Associated Vasculitis

Recent advances in the understanding of the pathogenesis of this disease have led to the identification of novel therapeutic targets that may address the problems of current treatments, including B and T cell–directed treatments, and those targeting innate immune elements.

Source:

Arthritis & Rheumatology